Relationship between plasma angiotensinII, leptin and arterial blood pressure

Saudi Medical Journal

Volumn 25, Issue 9, 2004, Pages 1193-1198

  Al Hazimi, Awdah M ^a   Syiamic, Ahmad Y ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; LEPTIN;

ADULT; ANGIOTENSIN BLOOD LEVEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OBESITY; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; ANGIOTENSIN II; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; LEPTIN; OBESITY; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 5044224468     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG. Obesity induced hypertension: new concepts from the emerging biology of obesity. Hypertension 1999; 33 (1 Pt 2): 537-541.
2. Richelsen B, Brun JM, Pedersen SB. Fatty tissues as a secretary organ. Significance for obesity-related diseases. Ugeskr laenger 2001; 163: 2913-2917.
3. Rosenbaum RL, Leibel JH. Medical progress: obesity. N Engl J Med 1997; 337: 396-407.
4. Kaplan NM. The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglycerimia, and hypertension. Arch Intern Med 1989; 149: 1514-1520.
5. Masuo K, Mikami H, Itoh M, Ogihara T, Tuck ML. Sympathetic activity and body mass index contribute to blood pressure level. Hypertens Res 2000; 23: 303-310.
6. Dyer AR, Elliott P, Shipley M, Stamler R, Stamler J. Body mass index and association of sodium and potassium with blood pressure in Intersalt. Hypertension 1994; 23 (6 Pt 1): 729-736.
7. Galicia MA, Brands MW, Hall JE. Hypertension in obese zucker rats. Hypertension 1996; 28: 1047-1054.
8. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105: 1243-1252.
9. Reaven GM. Role of insulin-resistance in human disease. Diabetes 1988; 37: 1595-1607.
10. Anderson EA, Mark AL. The vasodilator action of insulin: implication for the insulin hypothesis of hypertension. Hypertension 1993; 21: 136-141.
11. Hall JE. Mechanism of abnormal sodium handling in obesity hypertension. Am J Hypertens 1997; 10: 49S-55S.
12. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervatiuon attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25: 893-897.
13. Bray GA. Sympathetic nervous system, adrenergic receptors and obesity. J Lab Clin Med 1999; 134: 46.
14. Cooper R, McFaralane-Anderson N. ACE, AGT, and obesity. A potential pathway leading to hypertension. J Hum Hypertens 1997; 11: 107-111.
15. Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, Tewksbury D et al. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens 1997; 11: 107-111.
16. Bloem LJ, Mantunga AK, Tewksbury DA, Partt JH. The serum angiotensinogen concentration and variants of angiotensinogen gene in white and black children. J Clin Invest 1995; 95: 948-953.
17. Licata G, Scaglione R, Ganguzza A, Corrao S, Donatelli M, Parrinello G et al. Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens 1994; 7 (4 Pt 1): 314-320.
18. Egan BM, Stepniakowiski K, Goodfriend TL. Renin aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens 1994; 7: 886-893.
19. Philips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue renin angiotensin system. Regul Pept 1993; 43: 1-20.
20. Engeli S, Negral R, Sharma A. Physiology and pathophysiology of adipose tissue renin-angiotensin system. Hypertension 2000; 35: 1270-1277.
21. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chair BT, Rabinowitz D. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
22. Adamczak M, Kokot F, Wiecek AW. Relationship between plasma renin profile and leptinemia in patients with essential hypertension. J Hum Hypertens 2000; 14: 503-509.
23. Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 2000; 36: 538-542.
24. Arakawa K, Urata. H. Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis. Hypertension 2000; 36: 638-641.
25. Dimitori T, Huesermann S, Neubert A, Remer T. Measurements of urinary leptin and capillary leptin: alternative tools for the assessment of the leptin status? Horm Res 2001; 56: 93-97.
26. Sharma AM, Engeli S, Pischon T. New development in mechanisms of obesity-induced hypertension: role of adipose tissue. Curr Hypertens Res 2001: 3: 152-156.
27. Schorr U, Blaschke K, Turan S, Distler A, Sharma AM. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens 1998 16: 1475-1480.
28. Ailhaud G, Teboul M, Massiera F. Angiotensinogen, adipocyte differentiation and fat mass enlargement. Curr Opin Clin Nutr Metab Care 2002; 5: 385-389.
29. Amura K, Umemura S, Yamakawa T, Nyui N, Hibi K, Watanabe Y et al. Modulation of tissue angiotensinogen gene expression in genetically obese hypertensive rats. Am J Physiol 1997;272 (6Pt2): R1704-R1711.
30. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105: 1243-1252.
31. Hall JH. Pathophysiology of obesity hypertension. Curr Hypertens Res 2000; 2: 139-147.
32. Collin Bell A, Adair LS, Popkin BM. Ethnic differences in association between body mass index and hypertension. Am J Epidemiol 2002; 155: 346-353.
33. Allyn L, Marcelo C, Donald A, Ritchard A, William G. obesity-induced. Hypertension 1999; 33: 537-5411.
34. Osborn JW, Provr BJ, Montana JS, Trostel KA. Salt-sensitive hypertension caused by long term a-adrenergic blockade in the rat. Hypertension 1993; 21: 995-999.
35. Sato N. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increases in catecholamine secretion. Diabetes 1999; 48: 1787-1793.
36. Ogaway. Increased glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin. Diabetes 1999; 48: 1822-1829.
37. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409-414.
38. DiBona GF. Sympathetic nervous influences on the kidney: role of hypertension. Am J Hypertens 1989; 2: 119S-124S.
39. Wang G, Tang J, Chen M. Association of serum leptin concentration with blood pressure. Zhonghua Yi Xue Za Zhi 1999; 79: 664-667.
40. Schling P, Mallow H, Trindl A, Loffler G. Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relate Metab Disord 1999; 23: 446-441.
41. Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEBJ 2001; 15: 2727-2729.
42. Ganong WF. Origin of angiotensin II secreted by cells. Proc Soc Exp Biol Med 1994; 205: 213-219.
43. Adamczak M, Kokot F, Wiecek AW. Relationship between plasma renin profile and leptinemia in patients with essential hypertension. J Hum Hypertens 2000; 14: 503-509.
44. Messerli FH, Nunez BD, Ventura HO, Snyder DN. Overweight and sudden death. Arch Intern Med 1997; 147: 1725-1728.